Product ID: SQMIG35J2075
Cancer Pain Market Size, Share, Growth Analysis, By Drug(Opioids, Morphine), By Disease Indication(Lung Cancer, Colorectal Cancer) - Industry Forecast 2024-2031
Report ID:
SQMIG35J2075 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
71 |
Figures:
65
Cancer Pain Market Insights
Global Cancer Pain Market size was valued at USD 6.55 billion in 2022 and is poised to grow from USD 6.92 billion in 2023 to USD 10.70 billion by 2031, growing at a CAGR of 5.6% in the forecast period (2024-2031).
The expansion of the global cancer pain market is primarily propelled by factors including the growing cancer prevalence, an aging population, increased healthcare spending, and augmented research and development efforts by healthcare enterprises.
In 2020, for instance, the American Cancer Society reported approximately 1.8 million new cancer cases and around 606,520 cancer-related deaths in the U.S. Colorectal cancer saw about 1,065,960 new cases worldwide that same year, according to the International Agency for Research on Cancer.
Older individuals are more susceptible to various cancers due to age-related effects and genetic mutations. The National Cancer Institute indicates median diagnosis ages of 61 for breast cancer, 68 for colorectal cancer, 70 for lung cancer, and 66 for prostate cancer.
US Cancer Pain Market is poised to grow at a sustainable CAGR for the next forecast year.
Cancer Pain Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
